Andreas du Bois, MD | Authors


Extending Progression-Free Survival in Ovarian Cancer With Pazopanib

September 25, 2013

Andreas du Bois, MD, a professor of gynecologic oncology at Kliniken Essen Mitte in Essen, Germany, discusses a phase III trial exploring the effectiveness of treatment with maintenance pazopanib for patients with advanced ovarian cancer.